Literature DB >> 14506371

Survival of previously measles-vaccinated and measles-unvaccinated children in an emergency situation: an unplanned study.

Peter Aaby1, May-Lill Garly, Carlitos Balé, Cesario Martins, Henrik Jensen, Ida Lisse, Hilton Whittle.   

Abstract

BACKGROUND: Previous studies have suggested that standard measles vaccine may reduce mortality by more than the number of deaths thought to be caused by measles infection in areas with high mortality. However, these observations have not been based on randomized trials.
METHODS: During the recent war in Guinea-Bissau, most children fled from the city of Bissau and immunization services in the country broke down for several months. We were performing a trial in which children were randomized at 6 months of age to receive either measles vaccine or inactivated polio vaccine. Because of the war many children did not receive the dose of measles vaccine planned for 9 months of age. We were able to monitor mortality during the war and after.
RESULTS: Included in the study were 433 children 6 to 11 months of age. Fifteen children died (3.6%) during the first 3 months of the war before vaccination programs were resumed, 4 of 214 measles-vaccinated children and 11 of 219 children who had received inactivated polio vaccine. The effect of measles vaccine was marked for girls [mortality rate ratio (MR), 0.00; 95% confidence limits, 0.0 to 0.37], whereas there was no difference for boys (MR = 1.02; 95% confidence limits, 0.25 to 3.88). In a combined analysis controlling for factors that differed between the two groups, the MR for measles-vaccinated children was 0.30 (95% confidence limits, 0.08 to 0.87). Prolonging the period of observation to the end of 1998 or including the prewar period did not modify the significant beneficial effect of measles vaccine for girls. Twenty-two of the children in the cohort were reported to have had measles, 8 cases occurring during the 3 months of the war. Exclusion of measles cases in the analysis did not change the results; children who had received measles vaccine had a MR of 0.28 (95% confidence limits, 0.06 to 0.89) during the first 3 months of the war.
CONCLUSIONS: Consistent with previous observational studies, measles vaccination was associated with a reduction in mortality that cannot be explained by the prevention of measles infection. This nonspecific beneficial effect was particularly strong for girls. Further studies are needed to examine the extent of nonspecific effects in settings with high mortality.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14506371     DOI: 10.1097/01.inf.0000083821.33187.b5

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  17 in total

Review 1.  Effectiveness of measles vaccination and vitamin A treatment.

Authors:  Christopher R Sudfeld; Ann Marie Navar; Neal A Halsey
Journal:  Int J Epidemiol       Date:  2010-04       Impact factor: 7.196

Review 2.  A narrative review of nonspecific effects of pediatric vaccines on child mortality and morbidity.

Authors:  Muna Omar; Khitam Muhsen
Journal:  Hum Vaccin Immunother       Date:  2021-11-30       Impact factor: 3.452

3.  Non-specific effects of standard measles vaccine at 4.5 and 9 months of age on childhood mortality: randomised controlled trial.

Authors:  Peter Aaby; Cesário L Martins; May-Lill Garly; Carlito Balé; Andreas Andersen; Amabelia Rodrigues; Henrik Ravn; Ida M Lisse; Christine S Benn; Hilton C Whittle
Journal:  BMJ       Date:  2010-11-30

4.  The optimal age of measles immunisation in low-income countries: a secondary analysis of the assumptions underlying the current policy.

Authors:  Peter Aaby; Cesário L Martins; May-Lill Garly; Amabelia Rodrigues; Christine S Benn; Hilton Whittle
Journal:  BMJ Open       Date:  2012-07-19       Impact factor: 2.692

5.  Immunological Links to Nonspecific Effects of DTwP and BCG Vaccines on Infant Mortality.

Authors:  Mogens Helweg Claesson
Journal:  J Trop Med       Date:  2011-05-05

6.  Testing the hypothesis that diphtheria-tetanus-pertussis vaccine has negative non-specific and sex-differential effects on child survival in high-mortality countries.

Authors:  Peter Aaby; Christine Benn; Jens Nielsen; Ida Maria Lisse; Amabelia Rodrigues; Henrik Ravn
Journal:  BMJ Open       Date:  2012-05-22       Impact factor: 2.692

7.  Health effects of utilising hospital contacts to provide measles vaccination to children 9-59 months-a randomised controlled trial in Guinea-Bissau.

Authors:  Ane B Fisker; Justiniano S D Martins; Andreas M Jensen; Cesario Martins; Peter Aaby; Sanne M Thysen
Journal:  Trials       Date:  2022-04-23       Impact factor: 2.728

8.  Measles-mumps-rubella vaccination and respiratory syncytial virus-associated hospital contact.

Authors:  Signe Sørup; Christine Stabell Benn; Lone Graff Stensballe; Peter Aaby; Henrik Ravn
Journal:  Vaccine       Date:  2014-11-01       Impact factor: 3.641

9.  Protective efficacy of standard Edmonston-Zagreb measles vaccination in infants aged 4.5 months: interim analysis of a randomised clinical trial.

Authors:  Cesário L Martins; May-Lill Garly; Carlito Balé; Amabelia Rodrigues; Henrik Ravn; Hilton C Whittle; Ida M Lisse; Peter Aaby
Journal:  BMJ       Date:  2008-07-24

10.  Measles vaccination in the presence or absence of maternal measles antibody: impact on child survival.

Authors:  Peter Aaby; Cesário L Martins; May-Lill Garly; Andreas Andersen; Ane B Fisker; Mogens H Claesson; Henrik Ravn; Amabelia Rodrigues; Hilton C Whittle; Christine S Benn
Journal:  Clin Infect Dis       Date:  2014-05-14       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.